TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
ENGN

enGene Holdings Inc.

Healthcare · Biotechnology

1.90$ -2.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ENGN
Line item 2020 2021 2022 2023 2024 2025
– – – – – –
– +5.0% -12.5% -26.5% +84.6% +57.6%
– +190.0% -73.3% +2,874.1% +54.3% +81.2%
– -367.7% – -123.8% – +10,152.6%
– +29.2% -38.3% +107.8% +190.9% +60.5%
– +28.6% -38.1% +107.8% +39,507.9% -80.0%
– – +301.7% +17.2% -60.8% -105.4%
– +75.3% +24.2% +208.0% +208.4% -99.4%
– – +47.3% +548.7% +49.8% -234.3%
– – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?